Search Results

2008 FDA Guidelines for DES

The how and why of FDA oversight of drug-eluting stents.

By Andrew Farb, MD, and Ashley B. Boam, MS

2008 Drug-Eluting Stent Update

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

PFO Closure Technique

One expert's preferred method for successful closure of patent foramen ovale.

By Andrew D. Michaels, MD, MAS, FACC, FAHA

The Impact of Diabetes on PCI Case Selection

An evaluation of the current therapeutic options for patients with diabetes mellitus and cardiovascular disease.

By Victor Alfonso Jiménez Díaz, MD, and Andrés Iñiguez Romo, MD

PE Response Teams: Evolution Within the Revolution

Early adopters of the PERT concept share practical insights on forming an effective team.

Moderator: Rachel P. Rosovsky, MD, MPH;
Panelists: George Davis, PharmD; James Horowitz, MD; Brent Keeling, MD; Vicki McNally, MSN, RN, NP; John Moriarty, MD, FSIR; Soophia Naydenov, MD, FCCP; Fionnuala Ní Áinle, MD, PhD; and Charles B. Ross, MD, FACS, DFSVS

Stent Pipeline

An update on absorbable polymers and stents.

By Alexandre Abizaid, MD, PhD; Andre Lima Brito, MD; and J. Ribamar Costa Jr, MD

Bleeding Avoidance Strategies

Experts offer their experience with acute coronary syndrome protocol and how they approach access sites and handle bleeding events.

With Andrey Espinoza, MD, FACC, FSCAI; Paul A. Gurbel, MD; Sunil V. Rao, MD; and Steven J. Yakubov, MD, FACC, FSCAI

DAPT in STEMI

A panel of experts weighs in on STEMI pharmacology, transmission of prehospital ECGs by emergency medical services, and STEMI best practices for 2016.

With Moderator Andrey Espinoza, MD, FACC, FSCAI; and Panelists Peter B. Berger, MD; Paul A. Gurbel, MD; Charles Pollack, MA, MD, FACEP, FAAEM; and Marc Cohen, MD, FACC